slides · global inventory
Problem Agitate Solution
Arc collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 26,550
Current window 1,501-1,530
Pages 885
Rows per page 30
Arc
1,501-1,530 of 26,550
09
The chart displays the first principal component for each pathway over 20 weeks, comparing NurOwn and Placebo groups.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After2 hits
10
The slide uses a consistent color scheme (blue for NurOwn, red for Placebo) and indicates statistical significance with asterisks.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · SolutionLoop · Before After2 hits
11
The slide uses line charts with error bars to compare treatment effects across two subgroups (<=25 and >25 baseline ALSFRS-R).BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution2 hits
12
The slide uses four line charts to demonstrate treatment effects on biomarkers, showing statistical significance markers.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution2 hits
13
The slide uses color-coding to link specific biomarkers to biological pathways.BrainStorm Cell Therapeutics | Investor Presentation Deck | 15 slides · Brainstorm Cell Therapeutics
Conference presentation Investor relations Beat · Solution2 hits
19
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
20
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
21
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
22
Credit Suisse | Investor Event Presentation Deck | 43 slidesCredit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
23
The slide uses a chevron-based list format to map strategic pillars to specific quantitative targets.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
24
The slide uses a block-based organizational structure to illustrate the separation of core business units from those designated for wind-down or risk reduction.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
25
The slide uses a 4-row process/strategy framework to categorize business units. The charts show the reduction in RWA and Leverage Exposure from 2020 to 3Q22.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
26
The slide uses a stacked bar chart to illustrate the shift in RWA composition. The 'New Credit Suisse' grouping is a key strategic highlight.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
27
The slide uses a stacked bar chart to illustrate the strategic pivot of Credit Suisse's business model.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
28
The slide uses a waterfall-style chart to show the impact of capital raises on the CET1 ratio.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
29
The slide combines a summary table of capital raise details with a horizontal timeline of execution steps.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
30
Slide 30 of a presentation deck.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
31
The slide uses a process-oriented layout to define the operational framework for a business unit carve-out.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
32
The slide compares RWA (35bn) and Leverage Exposure (132bn) across five asset categories.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
33
The slide uses a process-style arrow to connect the progression charts to the expected outcomes by 2025.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
34
The chart uses a waterfall bridge structure to show capital movements.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
35
The slide uses a bridge/waterfall logic to show how strategic actions reduced the net impact of Basel III reforms from ~35-40bn to ~15bn.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
36
The slide uses a waterfall-style logic to show the reduction from 2022 guidance to 2025 target.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction2 hits
37
Includes specific targets like 2,700 FTE reduction and 50% reduction in consultancy spend.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Cost Of Inaction2 hits
38
The slide breaks down costs into specific time periods (3Q22-2024) and highlights a CET1 ratio impact.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
39
The chart uses a break in the axis to handle the large negative value of 9M22 reported RoTE.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
40
The slide uses a side-by-side layout connecting strategic actions to quantitative financial outcomes.Credit Suisse | Investor Event Presentation Deck | 43 slides · Credit Suisse
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
12
The slide shows a significant increase in Norepinephrine levels with Ampreloxetine treatment compared to placebo.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits
13
Study 0169 data showing significant increases in Norepinephrine and decreases in DHPG across three patient cohorts.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)Loop · Aha Moment2 hits
16
Includes a footer with abbreviations for BP, DHPG, MSA, NE, and nOH.Theravance Biopharma | Investor Conference Presentation Deck | 44 slides · Theravance Biopharma
Conference presentation Investor relations Beat · Solution (Provide relief)2 hits